Ligand validation:7D9X

GLY: GLYCINE

GLY is a Ligand Of Interest in 7D9X designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7D9X_GLY_D_601	74%	35%	0.122	0.951	0.94	1.59	-	-	0	0	100%	1
7D9X_GLY_B_602	55%	30%	0.185	0.953	1.15	1.61	1	-	0	0	100%	0.443
7D9X_GLY_D_602	53%	37%	0.15	0.911	0.96	1.51	-	-	0	0	100%	0.385
7D9X_GLY_B_601	40%	38%	0.155	0.865	0.94	1.49	-	-	0	0	100%	1
5ZJG_GLY_B_701	93%	38%	0.077	0.971	1.13	1.31	1	-	0	0	100%	1
7D9W_GLY_B_602	68%	31%	0.111	0.923	1.15	1.57	1	1	0	0	100%	1
4YKJ_GLY_A_302	99%	34%	0.06	0.995	1.1	1.49	1	-	1	0	100%	0.24
1VD5_GLY_A_401	99%	19%	0.055	0.989	1.83	1.65	2	1	0	0	100%	1
5I57_GLY_A_1001	98%	34%	0.058	0.984	0.83	1.75	-	2	1	0	100%	1
3KGR_GLY_B_801	98%	27%	0.063	0.986	1.29	1.65	1	1	0	0	100%	1
4OSY_GLY_A_402	98%	37%	0.067	0.986	1.06	1.42	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.